COVID-19 vaccine booster updates
May 2022Important Notices
"The U.S. Food and Drug Administration authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for adults age 50 and older and individuals age 12 and over who are moderately to severely immunocompromised.
The agency amended the emergency use authorizations as follows1:
For the most recent guidance on who can receive a booster shot, as well as specific recommendations for those who are moderately to severely immunocompromised, visit the CDC and FDA websites.
UPMC Health Plan is committed to ensuring that every eligible member has access to COVID-19 vaccines and resources to answer their questions about the COVID-19 vaccines. Health Plan members can find answers on our COVID-19 FAQ page—whether they are now eligible for boosters considering their first dose.
UPMC offers online scheduling for the COVID-19 vaccines; UPMC Health Plan members can also schedule by calling a Health Care Concierge at the number on the back of their ID card.
For the most recent COVID-19 policy and billing updates from UPMC Health Plan, please see these resources:
5/2022 Recall: Accupril Tablets
Pfizer is recalling batches of Accupril tablets (Quinapril HCl – 10 mg, 20 mg, and 40 mg) due to the presence of a nitrosamine, Nnitrosoquinapril, that was observed in recent testing at levels above the Acceptable Daily Intake (ADI) level. Read the full text of the Accupril Tablets recall."
The agency amended the emergency use authorizations as follows1:
- A second booster dose of the Pfizer-BioNTech COVID-19 Vaccine or Moderna COVID-19 Vaccine may be administered to individuals 50 years of age and older at least four months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine.
- A second booster dose of the Pfizer-BioNTech COVID-19 Vaccine or Moderna COVID-19 Vaccine may be administered to individuals who are moderately to severely immunocompromised at least four months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine. The Pfizer-BioNTech COVID-19 Vaccine may be in administered to individuals 12 years of age and older and the Moderna COVID-19 Vaccine may be administered to individuals 18 years of age and older.
- A second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines may be administered at least four months after the first booster to individuals who have received one primary dose of the Johnson & Johnson/Janssen Vaccine with one subsequent booster of any COVID-19 vaccine.
For the most recent guidance on who can receive a booster shot, as well as specific recommendations for those who are moderately to severely immunocompromised, visit the CDC and FDA websites.
UPMC Health Plan is committed to ensuring that every eligible member has access to COVID-19 vaccines and resources to answer their questions about the COVID-19 vaccines. Health Plan members can find answers on our COVID-19 FAQ page—whether they are now eligible for boosters considering their first dose.
UPMC offers online scheduling for the COVID-19 vaccines; UPMC Health Plan members can also schedule by calling a Health Care Concierge at the number on the back of their ID card.
For the most recent COVID-19 policy and billing updates from UPMC Health Plan, please see these resources:
Recent Announcements
Community Care Behavioral Health is excited to announce this free upcoming web-based training opportunity:
A growing body of U.S. and international research demonstrates that the rapid legalization and commercialization of gambling—including online casinos and mobile sports betting platforms—are associated with significant and escalating gambling related harm. Although Pennsylvania specific prevalence data remain limited, available evidence is increasingly concerning, with gambling disorder linked to alarmingly high rates of suicide, psychiatric comorbidity, and social and financial harm. Drawing on lessons from the tobacco and opioid crises, this presentation will examine how delayed recognition and regulation can amplify population level harm, underscoring the need for earlier screening, prevention, and policy engagement. Participants will gain practical guidance on identifying patients at elevated risk, implementing evidence informed screening and diagnostic strategies, and applying current treatment approaches across the lifespan.May 2026Education/Webinars
Bridging Smiles and Systems: Collaborative Care for Children with Chronic Conditions
Please join us for a live, CME-accredited and CEU-accredited webinar on May 13 from noon to 1p.m., that will explore the critical connection between oral health and pediatric chronic conditions such as diabetes, asthma, congenital heart disease, and ADHD.Apr. 2026Education/Webinars
Certified Community Health Worker (CCHW) Provider Billing Notification
UPMC for You will now reimburse for up to three certified community health worker (CCHW) visits per member per calendar year for Medicaid recipients, per the Pennsylvania Department of Human Services (PA DHS).Apr. 2026Important Notices